Lasa Supergenerics Limited (NSE:LASA)
India · Delayed Price · Currency is INR 6.24
+0.29 (4.87%)
Apr 2, 2026, 2:48 PM IST
Lasa Supergenerics Market Cap
Lasa Supergenerics has a market cap or net worth of 298.1 million as of April 2, 2026. Its market cap has decreased by -74.13% in one year.
Market Cap
298.10M
Enterprise Value
364.53M
Revenue
669.61M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.24
Market Cap Chart
Since September 22, 2017, Lasa Supergenerics's market cap has decreased from 3.53B to 298.10M, a decrease of -91.56%. That is a compound annual growth rate of -25.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 298.10M | -36.97% |
| Dec 31, 2025 | 472.96M | -62.89% |
| Dec 31, 2024 | 1.27B | -14.92% |
| Dec 29, 2023 | 1.50B | 9.45% |
| Dec 30, 2022 | 1.37B | -50.95% |
| Dec 31, 2021 | 2.79B | -18.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beta Drugs | 11.76B |
| Sakar Healthcare | 11.53B |
| Sigachi Industries | 6.96B |
| Valiant Laboratories | 2.91B |
| Bafna Pharmaceuticals | 2.59B |
| Nectar Lifesciences | 1.81B |
| Brooks Laboratories | 1.27B |
| Alpa Laboratories | 1.09B |